Cecilia C.S. Yeung
Appointments and Affiliations
M.D., Penn State College of Medicine, 2005
B.S., University of California, Davis, Biotechnology-Microbiology, 1999.
Molecular profiling of myelodysplastic syndromes and diagnostic markers of graft vs. host disease.
2010-2011: Molecular Genetics Pathology Fellowship; Washington University
2009-2010: Hematopathology Fellowship; Washington University
2005-2009: Anatomic and Clinical Pathology Residency; University of California Davis Medical Center
Association for Molecular Pathology, 2009-present
United States and Canadian Academy of Pathology, 2007-present
American Society of Clinical Pathologist, 2006-present
College of American Pathologist, 2005-present
American Association of Medical Colleges, 2005-present
Board Certification and Eligibility
Diplomat of the American Board of Pathology, Hematology, 2011-2021.
Diplomat of the American Board of Pathology, Anatomic and Clinical Pathology, 2009-2019
Medical Board of Missouri, 2009-2011
Medical Board of California, 2006-present
Diplomat of National Board of Medical Examiners, 2005-present
Drug Enforcement Administration, 2006-2012
Disruption of Iron Regulation after Radiation and Donor Cell Infusion.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 22(7):1173-81.. 2016.
Relapse after Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes - Analysis of Late Relapse Using Comparative Karyotype and Chromosome Genome Array Testing.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2015.
Rituximab is associated with improved survival in Burkitt lymphoma: a retrospective analysis from two US academic medical centers.. Therapeutic advances in hematology. 5(1):3-12.. 2014.